@article {2604, title = {Network Pharmacology-based Prediction and In Vivo Validation of Red Ginger and Turmeric Extract Combinations against Hypercoagulability in Isoproterenol-Induced Rats}, journal = {Pharmacognosy Journal}, volume = {18}, year = {2026}, month = {June 2026}, pages = {139-149}, type = {Original Article}, chapter = {139}, abstract = {

Background: Myocardial infarction is a critical cardiovascular condition often preceded by a hypercoagulable state. Red ginger (Zingiber officinale var. rubrum, ZOR) and turmeric (Curcuma longa L., CL) are recognized for their anticoagulant properties, yet their multi-target pharmacological interactions remain poorly understood. This study aimed to evaluate the anticoagulant potential of ZOR and CL combinations using an integrated network pharmacology and in vivo approach. Methods: Network pharmacology analysis was employed to predict potential molecular targets of ZOR and CL bioactive compounds. For in vivo validation, rats were treated with single extracts (300 mg/kg bw) or combinations (ratios 1:1, 1:3, 3:1), followed by isoproterenol-induced hypercoagulability. Anticoagulant activity was assessed by measuring Prothrombin Time (PT) and activated Partial Thromboplastin Time (aPTT). Results: Network pharmacology identified 10 key hub proteins, including STAT3, AKT1, and MTOR, indicating a multi-target mechanism. In vivo, isoproterenol effectively induced hypercoagulability. While ZOR (300 mg/kg BW) showed the highest individual potency, all combinations significantly prolonged PT and aPTT (p \< 0.05). Based on Chou-Talalay analysis, the interaction was dose-dependent; PT showed nearly additive to synergistic effects (CI: 0.86{\textendash} 1.07), whereas aPTT exhibited antagonistic trends (CI: 1.06{\textendash}1.50) at higher ZOR ratios. Consequently, combination effects remained stable without exceeding the most potent single dose. Conclusion: The ZOR and CL combination provides a consistent anticoagulant response through additive interactions, likely mediated by the modulation of the AKT/mTOR signaling axis and coagulation factors. This integration offers a promising, safer multi-target strategy for preventing thrombotic events in myocardial infarction.

}, keywords = {Anticoagulant, Coagulation, Curcuma longa, Isoproterenol, Network pharmacology, Zingiber officinale rubrum}, doi = {10.5530/pj.2026.18.127}, author = {Puspa SD. Solihah and Ellisa Clara Pasaribu and Fahmi Ahsanul Haq} } @article {2135, title = {The Investigation of The Network Pharmacology and Mechanism of Action of Centella Asiatica Extract on The Atopic Dermatitis Model}, journal = {Pharmacognosy Journal}, volume = {15}, year = {2023}, month = {October 2023}, pages = {881-890}, type = {Research Article}, chapter = {881}, abstract = {

Background: Atopic dermatitis (AD) is a chronic relapsing inflammatory skin condition which has a negative impact on children health. The well-known medicinal plant Centella asiatica extract (CE) is used in herbal skin care products to produce various pharmacological effects in dermatology. However, the molecular target of CE in suppressing inflammatory is largely unknown. Objective: the aim of this study was to examine anti-inflammatory properties and network pharmacology of CE in lipopolysaccharide (LPS)- induced AD in vitro model. Method: RAW264.7 cells were pre-treated with CE and then were stimulated with LPS and then were investigated cell viability, NO production, and the levels of pro-inflammatory mediators. In addition, the Search Tool for Retrieval of Interacting Genes (STRING), SwissTargetPrediction and the Kyoto Encyclopedia of Genes and Genomes (KEGG) were used to construct the defined mechanism of action and network pharmacology. Results: CE showed the potent inhibitory effects on LPS-induced NO. In addition, CE significantly suppressed the expression of iNOS and COX-2, as well as the production of IL-2, IL-6, IL-10, and TNF- α. Furthermore, the network pharmacological analysis revealed the potential role of CE in biological processes such as regulating JAK/STATs pathway and inhibiting proinflammatory cytokines both of which were linked to AD pathogenesis. Conclusion: Our findings confirm our hypothesis that CE could be developed as a therapeutic therapy for atopic dermatitis due to its pharmacological action and signaling mechanism in the modulation of allergic skin inflammation.

}, keywords = {Atopic dermatitis, Centella asiatica, Network pharmacology, Skin inflammation.}, doi = {10.5530/pj.2023.15.168}, author = {Sucharat Tungsukruthai and Runtikan Pochairach and Aungkana Krajarng and Piracha Jumpa-ngern and Parunkul Tungsukruthai} }